-

Quantori Named a Major Contender in Everest Group’s Pharmaceutical R&D IT Services PEAK Matrix® Assessment 2026

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Quantori, a provider of digital transformation services and technology for the life sciences and healthcare industries, has been named a Major Contender in Everest Group’s Pharmaceutical R&D IT Services PEAK Matrix® Assessment 2026. The assessment evaluates 34 service providers globally based on market impact and vision and capability.

Quantori has been recognized as a Major Contender in Everest Group’s Pharmaceutical R&D IT Services PEAK Matrix® Assessment 2026, highlighting its expertise in scientific data, AI, and digital transformation for pharmaceutical R&D.

Share

“We are pleased to be recognized as a Major Contender in Everest Group’s 2026 Pharmaceutical R&D IT Services PEAK Matrix® Assessment,” said Solman Rahman, Executive Vice President of Quantori. “This recognition underscores our ability to combine our deep scientific expertise with advanced AI and data capabilities. As AI-ready scientific data becomes foundational to R&D, we help clients turn GenAI and agentic AI into critical enablers that provide precise decision-making, better outcomes, and more efficient drug discovery.”

According to Everest Group, pharmaceutical companies are under growing pressure to improve R&D productivity. However, fragmented data and strict requirements for validation and oversight continue to limit the adoption of AI at scale. As a result, buyers are increasingly looking for providers that pair scientific and functional expertise with data, AI, and platform capabilities, the report finds.

This combination underpins Quantori's approach. The company supports pharmaceutical R&D through scientific informatics, data engineering, laboratory informatics, cloud and high-performance computing, with scientists and forward deployed engineers jointly developing solution accelerators and applying AI and machine learning to scientific data. Alongside these services, Quantori develops Q-Suite™, a set of AI-enabled accelerators for scientific data foundations, drug discovery, computational chemistry, and governed access to generative AI.

“R&D organizations are looking for practical ways to turn advances in AI, data, and digital technologies into meaningful scientific outcomes,” said Chris Waller, Chief Strategist at Quantori. “Our focus is on bridging science and technology to help researchers work more effectively with complex data and accelerate discovery and development.”

Learn more about Quantori’s R&D technology services and Q-Suite accelerators.

About PEAK Matrix®

The Everest Group PEAK Matrix® is a proprietary framework for assessing service providers based on their market impact and vision and capability. Market impact measures the impact created in the market, while vision and capability measures providers’ ability to successfully deliver services.

About Quantori

Quantori is a digital transformation and technology solutions company accelerating the digitization of life sciences and healthcare. Quantori transforms complex data into business value by combining deep industry knowledge, engineering excellence, and applied AI. Learn more at quantori.com and keep connected on social media X, LinkedIn, and Facebook.

Contacts

Media Contact:

Elizaveta Agafonova
Senior Marketing Manager
Email: elizaveta.agafonova@quantori.com

Quantori

Details
Headquarters: Cambridge, Massachusetts
CEO: Richard Golob
Employees: 500
Organization: PRI

Release Summary
Quantori has been named a Major Contender in Everest Group’s Pharmaceutical R&D IT Services PEAK Matrix® Assessment 2026
Release Versions

Contacts

Media Contact:

Elizaveta Agafonova
Senior Marketing Manager
Email: elizaveta.agafonova@quantori.com

Social Media Profiles
More News From Quantori

Quantori MLConfGen Wins “Machine Learning Innovation Award” in 2026 AI Breakthrough Awards Program

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Quantori's MLConfGen wins the Machine Learning Innovation Award at the 2026 AI Breakthrough Awards for advancing AI-assisted molecular design....

Quantori and Knowledge3 Announce Co-Marketing Partnership to Advance Knowledge-Driven AI in Life Sciences

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Quantori, a leading provider of digital transformation services and technology for the life sciences and healthcare industries, today announced a co-marketing partnership with Knowledge3 (K3), a company focused on bridging the gap between business goals and IT delivery through Knowledge Graphs, FAIR data principles, and graph-grounded Generative AI. The partnership brings together Quantori’s expertise in AI, scientific software engineering, and life sciences R...

ImmuVia Selects Quantori’s Q-Scientist Platform to Accelerate Development of First-in-Class Cancer Therapy

CAMBRIDGE, Mass.--(BUSINESS WIRE)--ImmuVia Inc., a biotechnology company developing first-in-class therapies for solid tumors, today announced that it has selected Quantori, a leading provider of digital transformation services and technology for the life sciences and healthcare industries, as a strategic technology partner. ImmuVia will deploy Quantori’s Q-Scientist platform to streamline computational workflows across its preclinical programs, with the goal of compressing development timeline...
Back to Newsroom